Literature DB >> 8651567

Insulin receptors in breast cancer.

A Belfiore1, L Frittitta, A Costantino, F Frasca, G Pandini, L Sciacca, I D Goldfine, R Vigneri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8651567     DOI： 10.1111/j.1749-6632.1996.tb16235.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  22 in total

Review 1.  Novel applications of COX-2 inhibitors, metformin, and statins for the primary chemoprevention of breast cancer.

Authors:  Darren Micallef; Sarah Micallef; Pierre Schembri-Wismayer; Jean Calleja-Agius
Journal:  J Turk Ger Gynecol Assoc       Date:  2016-12-01

2.  Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.

Authors:  Marilyn L Kwan; Wendy Y Chen; Candyce H Kroenke; Erin K Weltzien; Jeannette M Beasley; Sarah J Nechuta; Elizabeth M Poole; Wei Lu; Michelle D Holmes; Charles P Quesenberry; John P Pierce; Xiao Ou Shu; Bette J Caan
Journal:  Breast Cancer Res Treat       Date:  2011-12-21       Impact factor: 4.872

3.  Clinically defined type 2 diabetes mellitus and prognosis in early-stage breast cancer.

Authors:  Kirsten Erickson; Ruth E Patterson; Shirley W Flatt; Loki Natarajan; Barbara A Parker; Dennis D Heath; Gail A Laughlin; Nazmus Saquib; Cheryl L Rock; John P Pierce
Journal:  J Clin Oncol       Date:  2010-11-29       Impact factor: 44.544

4.  The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes.

Authors:  Shereen Ezzat; Lei Zheng; Jose C Florez; Norbert Stefan; Thomas Mayr; Maw Maw Hliang; Kathleen Jablonski; Maegan Harden; Alena Stančáková; Markku Laakso; Hans-Ulrich Haring; Axel Ullrich; Sylvia L Asa
Journal:  Cell Metab       Date:  2013-06-04       Impact factor: 27.287

5.  Type 2 diabetes mellitus and prognosis in early stage breast cancer women.

Authors:  Muhammet Ali Kaplan; Zafer Pekkolay; Mehmet Kucukoner; Ali Inal; Zuhat Urakci; Hamza Ertugrul; Recai Akdogan; Ugur Firat; Ismail Yildiz; Abdurrahman Isikdogan
Journal:  Med Oncol       Date:  2011-11-15       Impact factor: 3.064

6.  Highly specific role of the insulin receptor in breast cancer progression.

Authors:  Ran Rostoker; Sagi Abelson; Keren Bitton-Worms; Inna Genkin; Sarit Ben-Shmuel; Maria Dakwar; Zila Shen Orr; Avishay Caspi; Maty Tzukerman; Derek LeRoith
Journal:  Endocr Relat Cancer       Date:  2015-04       Impact factor: 5.678

7.  Improving health engagement and lifestyle management for breast cancer survivors with diabetes.

Authors:  Rebecca A Shelby; Caroline S Dorfman; Sarah S Arthur; Hayden B Bosworth; Leonor Corsino; Linda Sutton; Lynda Owen; Alaattin Erkanli; Francis Keefe; Cheyenne Corbett; Gretchen Kimmick
Journal:  Contemp Clin Trials       Date:  2020-04-11       Impact factor: 2.226

8.  Serum HER-2 concentration is associated with insulin resistance and decreases after weight loss.

Authors:  José Manuel Fernández-Real; Javier A Menendez; Gema Frühbeck; José María Moreno-Navarrete; Alejandro Vazquez-Martín; Wifredo Ricart
Journal:  Nutr Metab (Lond)       Date:  2010-02-25       Impact factor: 4.169

Review 9.  Sodium-glucose cotransporter-2 inhibitors: Understanding the mechanisms for therapeutic promise and persisting risks.

Authors:  Rachel J Perry; Gerald I Shulman
Journal:  J Biol Chem       Date:  2020-08-12       Impact factor: 5.157

Review 10.  Insulin resistance and hyperinsulinaemia in the development and progression of cancer.

Authors:  Ian F Godsland
Journal:  Clin Sci (Lond)       Date:  2009-11-23       Impact factor: 6.124
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.